1.What is the main committee responsible for identifying and mitigating risks associated with the medication system?

Patient Safety Committee

Medication Management Committee

Pharmacy Working Group

2.Which of the following are strategies employed for the safe use of Heparin at PRH?

Avoiding high concentrations of unfractionated heparin at PRH

Limiting the quantities of low molecular weight heparin stocked in patient care areas

Restricting the patient care areas where low molecular weight heparins are stocked 

All of the above

3.How often does the Pharmacy team complete an audit of unfractionated and low molecular weight heparin products in patient care areas?

Monthly

Weekly

At least annually

4.For a chance to win a gift card, please submit your PRH e-mail